News

Analyst Highlights Two Key Catalysts for Biotech

May 20, 2021 (Investorideas.com Newswire) The biopharma aTyr’s upcoming drug application and clinical-trial results are discussed in a ROTH Capital Partners report.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News